查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466005

表观遗传学市场：按产品、技术、工艺、应用和最终用户分类 - 全球预测 2024-2030

Epigenetics Market by Product, Technique, Methods, Application, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年表观遗传学市场规模为37.1亿美元，预计2024年将达41亿美元，2030年将达76.3亿美元，复合年增长率为10.82%。

表观遗传学是指对不涉及 DNA 序列变化的可遗传表型修饰的分析。我们可以在不改变基本遗传密码的情况下检查 DNA 和组蛋白中发生的化学修饰并影响基因表现。这些表观遗传变化可能受到年龄、环境和疾病状态等多种因素的影响，并作为可逆机制传递给下一代。表观遗传学为基因表现的控制增加了一层复杂性，对于我们对遗传学、发育和遗传的理解具有重要意义。表观遗传学的应用范围从生物医学研究到治疗性介入。在研究中，表观遗传学提供了对发育生物学和疾病发病机制的深入了解。在临床方面，它可用于癌症治疗、代谢紊乱和个人化医疗。典型的最终用户包括学术和研究机构、製药和生物技术公司以及诊断中心。由于全球慢性病和遗传患者病率的显着增加、政府在药物发现和开发方面的积极努力和投资以及对个人化医疗的日益关注，对錶观遗传学的需求正在增加。然而，表观遗传学技术的新兴市场面临着开发成本高、认知度低、表观遗传学适用范围窄等挑战，这些都阻碍了表观遗传学的普及。持续研究和开发表观遗传学的进展以及扩大表观遗传学在癌症以外领域的应用表明表观遗传学进步的潜在机会。

主要市场统计
基准年[2023] 37.1亿美元
预测年份 [2024] 41亿美元
预测年份 [2030] 76.3亿美元
复合年增长率（%） 10.82%

增加产品表观遗传学研究中试剂与套件的使用

酵素在表观遗传学研究中发挥着极其重要的作用，因为它们负责付加和去除表观遗传标记，例如 DNA 和组蛋白上的甲基。 DNA 修饰酶，例如DNA甲基转移酵素(DNMT) 和 TET 酶，是表观遗传修饰的重要工具，广泛用于研究 DNA 甲基化和羟甲基化模式。蛋白质修饰酶，例如组蛋白乙酰转移酶 (HAT)、去乙酰化酶 (HDAC)、甲基转移酵素和去甲基酶，可改变组蛋白并影响染色质结构和基因表现。表观遗传研究所需的工具，例如 DNA 定序仪、PCR 放大器、用于染色质剪切的超音波仪和先进的成像系统，是阐明表观遗传修饰的基础。这些仪器与微孔盘、移液管和软体等重要配件结合，有助于对表观遗传现象进行精确分析。专为表观遗传学研究量身定制的试剂和套件，例如亚硫酸氢盐转化套件和染色质免疫沉淀套件，可以帮助简化和标准化流程。 5-hmC 和 5-mC 分析套件简化了 DNA 甲基化和羟甲基化的检测和定量。针对甲基化胞嘧啶和各种组蛋白修饰等表观遗传标记的有效抗体对于西方印渍术、萤光和染色质免疫沉淀 (ChIP) 等技术至关重要。亚硫酸氢盐转换试剂套件将未甲基化的胞嘧啶残基转换为尿嘧啶，因此可以透过定序或 PCR 区分甲基化和未甲基化的 DNA，是 DNA 甲基化研究的基本方法。 ChIP-seq套件简化了染色质免疫沉淀和定序的过程。未修饰和转译后修饰的核心组蛋白及其变体可用于染色质重塑的体外研究以及了解特定修饰如何影响基因表现。全基因组扩增试剂套件有助于将纳克量的 DNA 扩增至微克水平，并且在起始材料有限时（例如在单细胞研究中）对于表观遗传分析至关重要。表观遗传学服务包括 DNA 甲基化分析、组蛋白修饰图谱和染色质可及性测定。这些专业服务利用亚硫酸氢盐测序等经典技术和下一代测序等现代高通量方法来支持研究人员获取和解释表观遗传资料。表观遗传学研究产生大量资料集，需要先进的生物资讯工具进行分析。软体解决方案提供资料处理、视觉化和整合平台，能够破解复杂的表观遗传网路。缺乏内部能力或寻求高度专业专业知识的研究机构越来越青睐服务。相反，软体起着补充作用，随着资料量和复杂性的增加，软体变得越来越重要。

技术 扩大次世代定序仪在全基因组甲基化分析的应用

质谱分析是一种估计离子质荷比的分析技术。它用于表观遗传学研究，分析 DNA 和组蛋白的变化，例如甲基化和乙酰化。这种方法非常准确，甚至可以检测表观遗传标记的微小变化。当需要高特异性和灵敏度或处理复杂混合物时，研究人员可能更喜欢质谱分析。次世代定序(NGS) 是一种强大的技术，可以对 DNA 和 RNA 进行高通量定序，对于了解整个基因组的遗传和表观遗传模式至关重要。 NGS 可用于表观遗传学应用，例如全基因组甲基化分析、染色质免疫沉淀定序 (ChIP-seq) 和 RNA 定序 (RNA-seq)，以研究转录水平的表观遗传学变化。当需要全面的全基因组分析或研究表观遗传学变化对基因表现的影响时，NGS 是首选。定量聚合酵素链锁反应(qPCR) 和聚合酵素链锁反应(PCR) 是用于扩增和定量特定 DNA 序列的技术。在表观遗传学中，这些方法可以量化特定基因的甲基化状态并测量由于表观遗传修饰而导致的基因表现的变化。 PCR 和 qPCR 供对特定 DNA 或 RNA 片段进行靶向分析而不是广泛的高通量方法感兴趣的研究人员使用。超音波处理是一种物理剪切过程，利用声能将核酸和蛋白质分解成更小的碎片。它通常在样品製备过程中用于表观遗传学，例如 ChIP-seq 方法，其中在进行免疫沉淀之前需要剪切染色质。当需要均匀剪切 DNA 时，尤其是在准备定序研究时，应选择超音波处理。此外，在选择这些表观遗传分析技术时，研究人员会考虑样本的性质、所需的分辨率以及所需资料的特异性和广度。质谱分析具有高度特异性，非常适合检测新的或微小的变化。 NGS 为全基因组分析提供全面、高通量的功能。

方法增加 X 染色体惰性中 DNA 甲基化的利用

DNA 甲基化是一种表观遗传修饰技术，当位于基因启动子时，会导致基因表现的抑制。它在多种生物过程中发挥重要作用，包括胚胎发育、X染色体惰性和重复元件的抑制。在研究早期发育阶段以及涉及印记和 X 染色体惰性的疾病时，首选 DNA 甲基化分析。分析 DNA 甲基化模式的技术包括亚硫酸氢定序、甲基化特异性PCR (MSP) 和基于阵列的方法。组蛋白修饰发生在 DNA 包裹的组蛋白上。组蛋白上各种胺基酸的化学基团（如甲基、乙酰基、磷酸盐和泛素）的付加或减少会影响染色质结构和基因活性。例如，乙酰化通常与转录活化相关，而甲基化可以活化或抑制基因表现，这取决于特定的胺基酸和付加的甲基的数量。染色质免疫沉淀分析法(ChIP)、随后的核苷酸定序(ChIP-seq)、基于质谱的方法和各种组蛋白修饰可用于研究基因调控、染色质动力学和对环境刺激的转录反应。修饰的研究是有利的，因为它。 DNA 甲基化和组蛋白修饰对于理解驱动基因表现的复杂调控网络至关重要。 DNA 甲基化分析对于稳定、长期的基因静默很重要的情况至关重要，例如发育生物学和疾病研究。相反，组蛋白修饰分析提供了染色质和转录变化的动态视图。它对于研究基因表现的快速变化以及环境因素对染色质结构的影响特别有用。

表观遗传学工具在应用肿瘤学的应用不断增加

由于全球与心臟相关的健康问题日益普遍，心血管疾病（CVD）已成为表观遗传学研究的主要焦点。表观遗传工具，包括 DNA 甲基化、组蛋白修饰和非编码 RNA 表达，被认为会影响 CVD 的发病和进展。旨在了解这些修饰的研究可能会导致识别潜在的生物标记物，用于早期检测和标靶治疗。发育生物学是表观遗传学研究的重要应用，揭示表观遗传学变化如何控制从胚胎发育到成年的发育过程。该领域的研究人员对发育过程中表观遗传谱如何变化以及这些变化如何导致发育障碍特别感兴趣。在免疫学中，表观遗传学应用于了解免疫反应的调节以及治疗自体免疫疾病、过敏和发炎的潜力。该应用领域在很大程度上依赖于对錶观遗传过程和免疫细胞分化之间相互作用的理解。这种需求是由对新疗法的需求所驱动的，治疗方法可以改变免疫系统的行为，而不会产生与现有治疗方法相关的副作用。代谢疾病的表观遗传学研究针对肥胖、糖尿病和其他代谢症候群等疾病。表观遗传学用于破解导致这些疾病的基因与环境的相互作用。该领域为旨在重置代谢特征的生物标记发现和表观遗传药物开发提供了一个富有成效的领域。鑑于表观遗传学修饰在癌症发展中的作用，肿瘤学是表观遗传学最突出的应用领域。针对 DNA 甲基化和组蛋白修饰酶的表观遗传药物已投入使用，并正在针对各种类型的癌症进行广泛研究。由于对精准医疗的需求和全球癌症的高负担，对錶观遗传学肿瘤学方法的需求是巨大的。肿瘤学是一个突出的领域，由于癌症相关死亡的影响很大，因此获得了大量投资和研究。因此，各种表观遗传药物正在稳步获得核准，形成了强大的治疗管道。

最终用户：学术和研究机构对錶观遗传学工具的需求不断增长

学术和研究机构已成为表观遗传学基础研究和发现的主要场所。这些机构对先进的研究工具有强烈的需求，例如次世代定序仪（NGS）、生物资讯平台以及表观遗传学套件和试剂。这里的重点是了解表观遗传变化的机制和影响，而不是直接的商业性应用。委外研发机构(CRO) 充当各种生物技术、製药和医疗设备公司的第三方服务供应商。我们提供各种服务，从早期研究到临床试验和上市后支援。在表观遗传学方面，CRO 需要最尖端科技，为药物发现和开发计划提供高通量能力和可靠的检验服务。 CRO 喜欢符合製药业严格监管标准的稳健、可扩展的解决方案。参与新药和治疗方法开发和商业化的製药和生物技术公司越来越受到表观遗传学见解的影响。这些公司需要一个全面的表观遗传学平台来简化药物发现、生物标记开发和治疗监测。製药和生物技术公司更喜欢能够加快上市速度、功效和安全性的整合解决方案。

区域洞察

北美表观遗传学市场主要由美国推动，原因是美国在研发方面的大量投资、製药和生物技术公司的强大实力以及癌症等慢性疾病的高发病率。在南美洲，表观遗传学的采用仍处于早期阶段，由于遗传疾病和癌症的盛行率不断增加，表观遗传学的应用具有发展的潜力。巴西支持表观遗传学的发展，因为其医疗保健部门不断发展，公众对先进治疗的认识不断提高。在中国、日本和印度等新兴经济体的推动下，亚太地区表观遗传学领域正经历快速转型。中国的专利申请迅速增加，显示政府和私人对錶观遗传学的强烈兴趣。日本政府正在鼓励精准医疗，从而增加了表观遗传学研究计画的资金。印度对表观遗传学研究的参与不断增加，合作和研究的数量也不断增加。欧洲表观遗传学市场强劲，以德国、英国和法国等国为首。广泛的研究活动、完善的医疗保健系统以及私营和公共部门不断增长的投资正在推动该地区的发展。此外，主要企业和学术机构之间的积极合作支持先进表观遗传疗法的开发。在中东地区，由于癌症等疾病盛行率的上升和医疗基础设施的扩张，表观遗传学正在逐渐发展。对个人化医疗的兴趣正在稳步增长并影响购买模式。在非洲，表观遗传学的发展仍处于早期阶段，研究设施有限。然而，由于医疗保健研究领域国际合作的增加，该领域仍有扩张的潜力。

FPNV定位矩阵

FPNV定位矩阵对于评估表观遗传学市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对錶观遗传学市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，以获得市场竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.表观遗传学市场的市场规模和预测是多少？

2.表观遗传学市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3.表观遗传学市场的技术趋势和法规结构是什么？

4.表观遗传学市场主要厂商的市场占有率是多少？

5. 进入表观遗传学市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地慢性病和遗传疾病的盛行率正在显着增加。
      • 政府对药物发现和开发的有利措施和投资
      • 个人化医疗的趋势日益增长
    • 抑制因素
      • 表观遗传学技术开发成本高
    • 机会
      • 持续进行表观遗传学的研究与发展活动
      • 将表观遗传学的应用扩展到非肿瘤学领域
    • 任务
      • 表观遗传学缺乏认识且应用有限
  • 市场区隔分析
    • 产品：增加表观遗传学研究试剂和套件的使用
    • 技术：扩大次世代定序在全基因组甲基化分析的应用
    • 方法：增加 X 染色体惰性中 DNA 甲基化的利用率
    • 应用：增加表观遗传学工具在肿瘤学的应用
    • 最终用户：学术和研究机构对錶观遗传学工具的需求不断增长
  • 市场趋势分析
    • 一家大公司进入美洲地区，正在进行旨在临床和农业应用以及技术进步的表观遗传学研究。
    • 随着人口老化的加剧，亚太地区的研发活动不断增加。
    • 欧洲、中东和非洲地区先进的医疗保健基础设施和与环境和农业应用相关的强大表观遗传学研究活动
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章表观遗传学市场：副产品

  • 酵素
  • 乐器及配件
  • 试剂和套件
  • 服务
  • 软体

第七章表观遗传学市场：依技术分类

  • 质谱
  • 次世代定序
  • 聚合酵素链锁反应与定量聚合酵素链锁反应
  • 超音波

第 8 章表观遗传学市场（依方法）

  • DNA甲基化
  • 组蛋白修饰

第九章表观遗传学市场：依应用分类

  • 心血管疾病
  • 发育生物学
  • 免疫学
  • 代谢性疾病
  • 肿瘤学

第 10 章表观遗传学市场：依最终使用者分类

  • 学术研究所
  • 合约调查机构
  • 製药和生物技术公司

第十一章美洲表观遗传学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区表观遗传学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的表观遗传学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Zenith 和 Sencora 合作加速 ZEN-3694 项目
    • FOXO 与 DataRobot 合作进行以人工智慧为基础的表观遗传生物标记研究
    • Zymo Research 和 Opentrons 合作实现新型无细胞 DNA 分离化学的自动化
    • MSU 生物化学家获得 NIH 280 万美元津贴，用于研究泛自闭症障碍的表观遗传学
    • 安捷伦宣布收​​购用于癌症研究的高性能 NGS靶向序列捕获工作流程开发商 Avida Biomed
    • Astra Zeneca推进产品线，在 AACR 上强调免疫肿瘤学、ADC、细胞治疗和表观遗传学的进展
    • Biomodal 发布遗传学和表观遗传学解决方案
    • Chroma Medicine 专注于表观遗传编辑
    • 易卜生收购 Epizyme 以扩大肿瘤产品组合
    • Zenith Epi Genetics 宣布开始由美国国家癌症研究所 (NCI) 赞助的多项肿瘤学临床试验

第15章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-0D217D5ADE3D

[190 Pages Report] The Epigenetics Market size was estimated at USD 3.71 billion in 2023 and expected to reach USD 4.10 billion in 2024, at a CAGR 10.82% to reach USD 7.63 billion by 2030.

Epigenetics refers to the analysis of heritable phenotype modifications that do not involve alterations in the DNA sequence. It examines the chemical modifications that occur on DNA and histone proteins, which can affect gene expression without changing the underlying genetic code. These epigenetic changes can be influenced by several factors, including age, environment, and disease state, and they are reversible mechanisms passed down to subsequent generations. Epigenetics provides an additional layer of complexity to the regulation of gene expression, and it has significant implications for our understanding of genetics, development, and inheritance. Applications of epigenetics span from biomedical research to therapeutic interventions. In research, epigenetics offers insights into developmental biology and the etiology of diseases. Clinically, it has implications in cancer treatment, metabolic disorders, and personalized medicine. The primary end-users include academic & research institutes, pharmaceutical & biotech companies, and diagnostic centers. The need for epigenetics is increasing due to substantial growth in the prevalence of chronic and genetic disorders worldwide, favorable governmental initiatives and investments in drug discovery and development, and a growing inclination toward personalized medicines. However, the market faces certain challenges, including the high cost of developing epigenetics technologies, lack of awareness, and limited application of epigenetics, hindering the adoption of epigenetics. Ongoing research and development activities for the advancement of epigenetics and expanding the application of epigenetics in non-oncology fields present potential opportunities for the development of epigenetics.

KEY MARKET STATISTICS
Base Year [2023] USD 3.71 billion
Estimated Year [2024] USD 4.10 billion
Forecast Year [2030] USD 7.63 billion
CAGR (%) 10.82%

Product: Increasing usage of reagents & kits for epigenetic research

Enzymes play a pivotal role in epigenetic research, as they are responsible for adding or removing epigenetic markers such as methyl groups on DNA or histones. DNA-modifying enzymes, such as DNA methyltransferases (DNMTs) and TET enzymes, are crucial tools in epigenetic modification, widely used in research to study DNA methylation and hydroxymethylation patterns. Protein-modifying enzymes such as histone acetyltransferases (HATs), deacetylases (HDACs), methyltransferases, and demethylases alter histone proteins, influencing chromatin structure and gene expression. The tools necessary for epigenetic research, such as DNA sequencers, PCR amplifiers, sonicators for chromatin shearing, and advanced imaging systems, are fundamental to elucidating epigenetic modifications. These instruments, paired with essential accessories such as microplates, pipettes, and software, facilitate the precise analysis of epigenetic phenomena. Reagents and kits tailored for epigenetic research, which include bisulfite conversion kits or chromatin immunoprecipitation kits, serve to streamline and standardize processes. 5-hmC & 5-mC analysis kits simplify detecting and quantifying DNA methylation and hydroxymethylation. Validated antibodies against epigenetic markers such as methylated cytosine or various histone modifications are indispensable for techniques such as western blotting, immunofluorescence, and chromatin immunoprecipitation (ChIP). Bisulfite conversion kits convert unmethylated cytosine residues to uracil, which enables the discrimination of methylated from unmethylated DNA via sequencing or PCR, serving as a cornerstone method in DNA methylation studies. ChIP-seq kits streamline the process of performing chromatin immunoprecipitation followed by sequencing. Unmodified and post-translationally modified core histone proteins and their variants are utilized for in vitro studies of chromatin remodeling and to understand how specific modifications influence gene expression. Whole genome amplification kits facilitate the amplification of nanogram quantities of DNA to microgram levels, which is essential for epigenetic analysis when starting material is limited, such as in single-cell studies. Epigenetics services include DNA methylation profiling, histone modification mapping, and chromatin accessibility assays. These specialized services leverage classic techniques, such as bisulfite sequencing, and modern high-throughput methods, such as next-generation sequencing, to support researchers in epigenetic data acquisition and interpretation. Epigenetics research yields large datasets that necessitate sophisticated bioinformatics tools for analysis. Software solutions provide data processing, visualization, and integration platforms, enabling the decoding of complex epigenetic networks. Services are increasingly becoming preferred for research entities lacking in-house capabilities or those looking for highly specialized expertise. Conversely, the software serves a complementary role, growing in importance as the volume and complexity of data escalate.

Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling

Mass spectrometry is an analytical method that estimates the mass-to-charge ratio of ions. It is used in epigenetic studies to analyze DNA and histone changes, such as methylation and acetylation. The method is very precise, allowing for the detection of even small changes in epigenetic marks. Researchers may prefer mass spectrometry when they require high specificity and sensitivity or deal with complex mixtures. Next-generation sequencing (NGS) is a powerful method that allows for high-throughput sequencing of DNA and RNA, which is critical for understanding genetic and epigenetic patterns across the genome. NGS can be used for epigenetic applications such as genome-wide methylation profiling, chromatin immunoprecipitation sequencing (ChIP-seq), and RNA sequencing (RNA-seq) to study epigenetic changes at the transcriptional level. NGS is preferred when comprehensive, genome-wide analysis is required or while examining the effects of epigenetic changes on gene expression. Quantitative polymerase chain reaction (qPCR)and polymerase chain reaction (PCR) are techniques used to amplify and quantify specific DNA sequences. In epigenetics, these methods can quantify the methylation status of particular genes or measure gene expression changes resulting from epigenetic modification. PCR and qPCR are used by researchers that are interested in targeted analysis of specific DNA or RNA fragments rather than a broad, high-throughput approach. Sonication is a physical shearing process that uses sound energy to break nucleic acids and proteins into smaller fragments. It is often used in epigenetics during the preparation of samples for methods such as ChIP-seq, where chromatin must be sheared before immunoprecipitation can occur. Sonication is selected when uniform shearing of DNA is necessary, particularly in preparation for sequencing studies. Moreover, when choosing among these epigenetic analysis techniques, researchers consider the nature of their sample, the resolution needed, and the specificity and breadth of data they require. Mass spectrometry offers high specificity, making it ideal for detecting novel or small changes. NGS presents comprehensive and high-throughput capabilities for whole-genome analysis.

Methods: Rising utilization of DNA methylation for X-chromosome inactivation

DNA methylation is an epigenetic modification technique that leads to the repression of gene expression when located in gene promoters. It plays a critical role in diverse biological processes such as embryonic development, X-chromosome inactivation, and suppression of repetitive elements. DNA methylation analysis is preferred when studying early developmental stages and diseases that involve imprinting or X-chromosome inactivation. Techniques utilized for analyzing DNA methylation patterns include bisulfite sequencing, methylation-specific PCR (MSP), and array-based methods. Histone modifications occur on the histone proteins around which DNA is wound. The addition or reduction of chemical groups such as methyl, acetyl, phosphate, and ubiquitin to various amino acids on histones can affect chromatin structure and gene activity. Acetylation, for instance, is generally associated with transcriptional activation, while methylation can activate or suppress gene expression, relying on the specific amino acid and the number of methyl groups added. Research in gene regulation, chromatin dynamics, and transcriptional response to environmental stimuli can favor histone modification studies as it includes chromatin immunoprecipitation (ChIP) followed by sequencing (ChIP-seq), mass spectrometry-based methods and specific antibodies that recognize various histone modifications. DNA methylation and histone modifications are paramount for understanding the complex regulatory networks that drive gene expression. DNA methylation analyses are indispensable in certain contexts, such as developmental biology and disease studies where stable, long-term gene silencing is crucial. In contrast, histone modification analyses offer a dynamic view of chromatin and transcriptional changes. They are particularly beneficial for investigating rapid gene expression changes and the effects of environmental factors on chromatin structure.

Application: Increasing application of epigenetic tools in oncology

Cardiovascular diseases (CVDs) are a major area of focus for epigenetic research due to the increasing prevalence of heart-related health issues globally. Epigenetic tools, including DNA methylation, histone modification, and non-coding RNA expression, are believed to influence the development and progression of CVDs. Studies aimed at understanding these modifications could lead to identifying potential biomarkers for early detection and targeted therapies. Developmental biology is a critical application for epigenetic research, illuminating how epigenetic changes govern development processes from embryogenesis to adulthood. Researchers in this field are particularly interested in the way epigenetic profiles change during development, and they can result in developmental disorders when altered. In immunology, epigenetics applies to understanding the regulation of immune response and the potential to treat autoimmune diseases, allergies, and inflammatory conditions. The application segment relies heavily on understanding the interaction between epigenetic processes and immune cell differentiation. The need is propelled by the need for new therapeutic methods that modify immune system behavior without the adverse effects associated with current treatments. Epigenetic research in metabolic diseases targets conditions such as obesity, diabetes, and other metabolic syndromes. Epigenetics is used to decipher the gene-environment interactions contributing to such diseases. This arena provides fruitful ground for biomarker discovery and epigenetic drug development aimed at resetting metabolic profiles. Oncology is the most prominent application of epigenetics, given the role of epigenetic modifications in cancer development. Epigenetic drugs targeting DNA methylation and histone modification enzymes are already in use and are being studied extensively for various types of cancers. The need for epigenetic oncology approaches is immense, driven by the need for precision medicine and the high burden of cancer worldwide. Oncology, as a prominent segment, has witnessed significant investment and research due to the high impact of cancer-related deaths. It has steadily resulted in various approved epigenetic drugs and a robust pipeline of therapies.

End-User: Growing need for epigenetic tools from academic & research institutes

Academic and research institutes serve as primary grounds for basic research and discovery in epigenetics. These institutions strongly need advanced research tools such as next-generation sequencing (NGS), bioinformatics platforms, and epigenetic kits and reagents. The focus here is largely on understanding the mechanisms and implications of epigenetic changes rather than immediate commercial applications. Contract research organizations (CROs) operate as third-party service providers for various biotechnology, pharmaceutical, and medical device companies. They perform various services, from early-stage research to clinical trials and post-market support. In epigenetics, CROs need cutting-edge technologies that offer high-throughput capabilities and reliable validation services for drug discovery and development projects. CROs prefer robust, scalable solutions aligned with the pharmaceutical industry's stringent regulatory standards. Pharmaceutical and biotechnology companies are involved in developing and commercializing new drugs and treatments and an increasing number of these companies are being influenced by epigenetic insights. These companies require comprehensive epigenetic platforms that can streamline drug discovery, biomarker development, and therapeutic monitoring. The preference for pharma and biotech is for integrated solutions that deliver speed to market, efficacy, and safety.

Regional Insights

The epigenetics market in North America has exhibited substantial growth, primarily driven by the United States, attributed to heavy investments in research and development, the robust presence of pharmaceutical and biotechnology companies, and a high incidence rate of chronic diseases such as cancer. In South America, the adoption of epigenetics is in the nascent stage and has a potential for development due to the increasing prevalence of genetic disorders and cancers, and Brazil supports the development of epigenetics with an evolving healthcare sector and growing public awareness about advanced treatments. The APAC region is undergoing a rapid transition in the epigenetics sector due to emerging economies such as China, Japan, and India. China has witnessed a surge in patent filings, indicating strong governmental and private interest in epigenetics. The Japanese government encourages precision medicine, resulting in increased funding for epigenetic research programs. India's participation in epigenetic research is expanding, with an increasing number of collaborations and studies. Europe's epigenetics market is robust, led by countries such as Germany, the UK, and France. Extensive research activities, well-established healthcare systems, and growing investments from the private and public sectors propel the regional development. Additionally, active collaborations between key players and academic institutions support the development of advanced epigenetic therapies. The Middle East region is experiencing gradual progress in epigenetics due to the rising prevalence of conditions such as cancer and the expansion of healthcare infrastructure. The interest in personalized medicine is steadily gaining traction, influencing purchasing patterns. In Africa, the development of epigenetics is in the early stages, with limited research facilities. However, there is potential for expansion with increasing international collaboration in healthcare research.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Epigenetics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Epigenetics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Epigenetics Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Active Motif, Inc., Agilent Technologies, Inc., AstraZeneca PLC, Bayer AG, Bio-Rad Laboratories, Inc., BioCat GmbH by AddLife AB, Bioneer Corporation, BPS Bioscience, Inc., Bristol-Myers Squibb Company, Cambridge Epigenetix Ltd., Chroma Medicine, Inc., Creative Biogene, Creative Diagnostics, Cusabio Technology LLC, Diagenode S.A. by Hologic, Inc., Elysium Health, Inc., EpiCypher, Inc., Epigenic Therapeutics, EpiGentek Group Inc., Eurofins Scientific SE, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Fios Genomics Ltd., FOXO Technologies Inc., GenomeScan, GenScript Biotech Corporation, Gilead Sciences, Inc., Illumina, Inc., Integrated DNA Technologies, Inc. by Danaher Corporation, Ipsen, Lonza Group Ltd., Merck KGaA, MorphoSys AG, New England Biolabs, Inc., Novogene Co, Ltd., Omega Therapeutics, Inc., Pacific Biosciences of California, Inc, PerkinElmer, Inc., Promega Corporation, ProteoGenix SAS, Qiagen N.V., Sound Agriculture Company, STORM Therapeutics LTD, Takara Holdings Inc., Thermo Fisher Scientific Inc., Twist Bioscience Corporation, Watchmaker Genomics, Inc., Zenith Epigenetics Ltd., and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Epigenetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Enzymes
      • DNA-Modifying Enzymes
      • Protein-Modifying Enzymes
    • Instruments & Accessories
    • Reagents & Kits
      • 5-hmC & 5-mC Analysis Kit
      • Antibodies
      • Bisulfite Conversion Kits
      • ChiP-seq Kits
      • Histones
      • Whole Genome Amplification Kits
    • Service
    • Software
  • Technique
    • Mass Spectrometry
    • Next-Generation Sequencing
    • Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
    • Sonication
  • Methods
    • DNA Methylation
    • Histone Modifications
  • Application
    • Cardiovascular Diseases
    • Developmental Biology
    • Immunology
    • Metabolic Diseases
    • Oncology
  • End User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Epigenetics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Epigenetics Market?

3. What are the technology trends and regulatory frameworks in the Epigenetics Market?

4. What is the market share of the leading vendors in the Epigenetics Market?

5. Which modes and strategic moves are suitable for entering the Epigenetics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant growth in the prevalence of chronic and genetic disorders worldwide
      • 5.1.1.2. Favorable governmental initiatives and investments in drug discovery and development
      • 5.1.1.3. Growing inclination toward personalized medicines
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of epigenetics technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development activities for the advancement of epigenetics
      • 5.1.3.2. Expanding the application of epigenetics in non-oncology fields
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and limited application of epigenetics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing usage of reagents & kits for epigenetic research
    • 5.2.2. Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling
    • 5.2.3. Methods: Rising utilization of DNA methylation for X-chromosome inactivation
    • 5.2.4. Application: Increasing application of epigenetic tools in oncology
    • 5.2.5. End-User: Growing need for epigenetic tools from academic & research institutes
  • 5.3. Market Trend Analysis
    • 5.3.1. Continuous epigenetics research for clinical and agricultural applications and technological advancements with a presence of major players in the Americas region
    • 5.3.2. Increasing research and development activities coupled with growing geriatric population in the APAC region
    • 5.3.3. Advanced healthcare infrastructure and strong epigenetics research activities associated with environment and agricultural applications in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Epigenetics Market, by Product

  • 6.1. Introduction
  • 6.2. Enzymes
  • 6.3. Instruments & Accessories
  • 6.4. Reagents & Kits
  • 6.5. Service
  • 6.6. Software

7. Epigenetics Market, by Technique

  • 7.1. Introduction
  • 7.2. Mass Spectrometry
  • 7.3. Next-Generation Sequencing
  • 7.4. Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
  • 7.5. Sonication

8. Epigenetics Market, by Methods

  • 8.1. Introduction
  • 8.2. DNA Methylation
  • 8.3. Histone Modifications

9. Epigenetics Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Developmental Biology
  • 9.4. Immunology
  • 9.5. Metabolic Diseases
  • 9.6. Oncology

10. Epigenetics Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Epigenetics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Epigenetics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Epigenetics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Zenith and Cencora Partner to Expedite ZEN-3694 Programme
    • 14.3.2. FOXO, DataRobot Partner for AI-Based Epigenetic Biomarker Research
    • 14.3.3. Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry
    • 14.3.4. MSU biochemist Receives USD 2.8 million NIH Grant For Epigenetic Research on Autism Spectrum Disorder
    • 14.3.5. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
    • 14.3.6. AstraZeneca Advances its Pipeline and Highlights Progress in Immuno-Oncology, ADCs, Cell Therapy and Epigenetics At AACR
    • 14.3.7. Biomodal Releases Genetics And Epigenetics Solution
    • 14.3.8. Chroma Medicine Raises Stakes in Epigenetic Editing
    • 14.3.9. Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
    • 14.3.10. Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. EPIGENETICS MARKET RESEARCH PROCESS
  • FIGURE 2. EPIGENETICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. EPIGENETICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPIGENETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL EPIGENETICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 104. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 118. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 125. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 126. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 132. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 139. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 140. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 141. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 142. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 143. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 155. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 156. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 157. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 160. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 161. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 162. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 184. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 185. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 186. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 187. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 188. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 189. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 192. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 196. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 197. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 198. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 199. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 200. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 201. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 202. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 203. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 206. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 207. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 208. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 209. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 210. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 211. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 212. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 213. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 214. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 215. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 216. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 217. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 224. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 225. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 226. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 227. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 228. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 229. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 230. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 231. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 238. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 239. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 240. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 241. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 242. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 243. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 244. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 245. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 248. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 249. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 252. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 253. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 254. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 255. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 256. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 257. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 258. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 259. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 262. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 264. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 266. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 268. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 270. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 271. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 272. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 273. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 276. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 277. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 280. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 281. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 282. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 283. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 284. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 285. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 286. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 287. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 290. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 292. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 294. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 296. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 298. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 299. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 300. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 301. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 304. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 305. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 306. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 307. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 308. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 309. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 310. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 311. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 312. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 313. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 314. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 315. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 318. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 319. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 322. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 323. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 324. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 325. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 326. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 327. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 328. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 329. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 332. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 333. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 336. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 337. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 338. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 339. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 340. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 341. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 342. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 343. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 344. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 345. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 346. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 347. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 348. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 349. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 350. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 351. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 352. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 353. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 354. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 355. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 356. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 357. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 360. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 361. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 362. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 363. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 364. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 365. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 366. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 367. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 368. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 369. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 370. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 371. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 372. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 373. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 374. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 375. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 376. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 377. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 378. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 379. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 380. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)

TABL